AbbVie’s multiple legacy LIMS systems were difficult to use and differed between teams and even countries, reducing productivity and collaboration.
We conducted 51 interviews across functional areas and regional R&D groups, yielding consensus best practices that could be standardized and pushed out organization-wide. Applying the validated experiences and input of company scientists, we collaborated with the key stakeholders and development teams at AbbVie to launch a new global LIMS in 5 months.
The new global LIMS automates repetitive tasks and streamlines collaboration, enabling the organization to derive new value by leveraging its global talent in new types of teams.